Jayanshu Jain

Jayanshu Jain's work focuses on clinical outcomes research in hematology and oncology, particularly blood cancers like acute myeloid leukemia, multiple myeloma, and polycythemia vera, as well as urothelial (bladder) and kidney cancers. Much of this research examines how patients respond to treatments such as immune checkpoint inhibitors, targeted drug combinations, and stem cell transplantation, often using retrospective patient data and clinical trial results to identify prognostic factors and treatment patterns.

Publication output was minimal before 2019, rose sharply in 2021 and again in 2025-2026, with some fluctuation in between, suggesting an overall growing but uneven publication pace over the last decade.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026